Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

341
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
341
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

163
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
163
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

178
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
178
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

405
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
405
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

336
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
336
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

226
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
226

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Circulation·2026
Same author

Observational Comparative Research in Cardiovascular and Brain Health and Disease: A Scientific Statement From the American Heart Association.

Circulation·2026
Same author

A comprehensive multidisciplinary thoracic aortic program improves patient quality metrics after type A aortic dissection repair.

JTCVS open·2026
Same author

Sex-Specific Considerations for Mitral Valve Intervention: An Opportunity for Collaboration.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2026
Same author

Valvular heart failure: evolving pharmacological approaches.

European heart journal·2026
Same author

Institutional impact of multidisciplinary aortic team implementation on practice patterns and surgical productivity.

Seminars in vascular surgery·2025

Related Experiment Video

Updated: Jan 3, 2026

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.5K

Aortic Stenosis: Guidelines and Evidence Gaps.

Andrew W Harris1, Philippe Pibarot2, Catherine M Otto1

  • 1Department of Medicine, Division of Cardiology, University of Washington, 1959 Northeast Pacific Street, Box 356422, Seattle, WA 98195, USA.

Cardiology Clinics
|November 23, 2019
PubMed
Summary
This summary is machine-generated.

Current guidelines recommend aortic valve replacement for severe aortic stenosis. Advances in transcatheter aortic valve replacement (TAVR) show favorable outcomes, even in low-risk patients, prompting a review of existing recommendations.

Keywords:
Aortic stenosisControversiesEvidence gapsGuidelines

More Related Videos

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

16.6K

Related Experiment Videos

Last Updated: Jan 3, 2026

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.5K
Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

16.6K

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Current guidelines advocate aortic valve replacement for severe aortic stenosis with clinical consequences.
  • Technological advancements have reduced risks and improved outcomes for both surgical and transcatheter aortic valve replacement (TAVR).

Purpose of the Study:

  • To review current guideline recommendations for aortic stenosis management.
  • To highlight key controversies and evidence gaps in the treatment of aortic stenosis.

Main Methods:

  • Review of current clinical guidelines for aortic stenosis.
  • Analysis of recent clinical trial data comparing TAVR and surgical AVR, particularly in low-risk populations.

Main Results:

  • Transcatheter aortic valve replacement (TAVR) is established for prohibitive-risk patients and reasonable for intermediate/high-risk individuals.
  • Recent trials indicate favorable short-term outcomes for TAVR compared to surgical AVR in low-risk patients.

Conclusions:

  • The evolving landscape of aortic stenosis treatment necessitates a re-evaluation of current management guidelines.
  • Evidence gaps remain, particularly concerning the long-term efficacy and optimal patient selection for TAVR in lower-risk surgical candidates.